|
Cortivazol
|
H02AB17 |
|
|
Invasive_fungal_infection
|
Invasive_fungal_infection |
|
|
unit_per_milliliter
|
unit_per_milliliter |
|
|
Pedal_edema
|
Pedal_edema |
|
|
bronchopneumonia
|
bronchopneumonia |
|
|
Percent_Predicted_Forced_Vital_Capacity
|
Percent_Predicted_Forced_Vital_Capacity |
|
|
Opinercept
|
L04AB07 |
|
|
Afelimomab
|
L04AB03 |
|
|
Adalimumab
|
L04AB04 |
|
|
Certolizumab pegol
|
L04AB05 |
|
|
Golimumab
|
L04AB06 |
|
|
double_filtration_plasmapheresis
|
double_filtration_plasmapheresis |
|
|
Infection_parameters
|
Infection_parameters |
|
|
Etanercept
|
L04AB01 |
|
|
Infliximab
|
L04AB02 |
|
|
rectum
|
rectum |
|
|
How_long_under_continuous_usage_of_corticosteroids
|
How_long_under_continuous_usage_of_corticosteroids |
|
|
Bilirubin:MCnc:Pt:CSF:Qn
|
Bilirubin:MCnc:Pt:CSF:Qn |
|
|
International_Unit_per_Kilogram_per_Hour
|
International_Unit_per_Kilogram_per_Hour |
|
|
Staphylococcus_aureus_as_the_cause_of_diseases_classified_to_other_chapters
|
Staphylococcus_aureus_as_the_cause_of_diseases_classified_to_other_chapters |
|
